News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
15,147 Results
Type
Article (328)
Company Profile (6)
Press Release (14813)
Section
Business (8325)
Career Advice (6)
Deals (961)
Drug Development (1301)
FDA (141)
Job Trends (340)
News (10004)
Policy (336)
Tag
Academia (46)
Allergies (1)
Alliances (341)
ALS (5)
Alzheimer's disease (53)
Antibody-drug conjugate (ADC) (2)
Approvals (151)
Artificial intelligence (4)
Autoimmune disease (4)
Bankruptcy (4)
Best Places to Work (342)
Biosimilars (1)
Biotechnology (7)
Bladder cancer (14)
Breast cancer (5)
Cancer (85)
Cardiovascular disease (4)
Career advice (6)
CAR-T (5)
Cell therapy (11)
Cervical cancer (1)
Clinical research (1138)
Collaboration (19)
Compensation (23)
Complete response letters (2)
COVID-19 (28)
CRISPR (2)
C-suite (3)
Cystic fibrosis (2)
Data (151)
Diabetes (7)
Diagnostics (211)
Digital health (6)
Drug discovery (2)
Duchenne muscular dystrophy (24)
Earnings (8621)
Events (1598)
Executive appointments (3)
FDA (282)
Funding (16)
Gene editing (7)
Gene therapy (7)
GLP-1 (11)
Government (49)
Grass and pollen (1)
Guidances (110)
Healthcare (610)
Immunology and inflammation (6)
Immuno-oncology (3)
Indications (3)
Infectious disease (32)
Inflammatory bowel disease (5)
Intellectual property (1)
IPO (788)
Job creations (16)
Job search strategy (6)
Layoffs (8)
Legal (32)
Liver cancer (3)
Lung cancer (8)
Lymphoma (19)
Manufacturing (10)
MASH (5)
Medical device (455)
Medtech (460)
Mergers & acquisitions (185)
Metabolic disorders (17)
mRNA (2)
Multiple sclerosis (3)
NASH (2)
Neurodegenerative disease (5)
Neuroscience (74)
NextGen: Class of 2026 (82)
Non-profit (41)
Obesity (5)
Opinion (1)
Ovarian cancer (2)
Parkinson's disease (3)
Patient recruitment (4)
People (335)
Pharmaceutical (1)
Phase 1 (306)
Phase 2 (484)
Phase 3 (449)
Pipeline (460)
Postmarket research (35)
Preclinical (115)
Prostate cancer (5)
Radiopharmaceuticals (7)
Rare diseases (17)
Real estate (31)
Regulatory (306)
Reports (2)
Research institute (49)
Rett syndrome (2)
RSV (3)
Schizophrenia (2)
Series A (2)
Series B (1)
Service/supplier (1)
Sickle cell disease (3)
Special edition (2)
Spinal muscular atrophy (2)
Sponsored (1)
Startups (33)
Vaccines (13)
Women's health (4)
Date
Last 7 days (16)
Last 30 days (90)
Last 365 days (935)
2026 (242)
2025 (939)
2024 (1058)
2023 (1154)
2022 (4309)
2021 (1178)
2020 (924)
2019 (744)
2018 (585)
2017 (369)
2016 (259)
2015 (448)
2014 (274)
2013 (166)
2012 (208)
2011 (268)
2010 (323)
Location
Africa (3)
Alabama (2)
Arizona (7)
Asia (1009)
Australia (71)
California (418)
Canada (99)
China (17)
Colorado (23)
Connecticut (13)
Delaware (25)
Europe (1785)
Florida (49)
Georgia (14)
Idaho (3)
Illinois (21)
India (2)
Indiana (21)
Japan (13)
Kansas (4)
Kentucky (3)
Louisiana (4)
Maine (7)
Maryland (39)
Massachusetts (224)
Michigan (6)
Minnesota (28)
Missouri (4)
Nevada (1)
New Hampshire (6)
New Jersey (88)
New York (97)
North Carolina (35)
Northern California (237)
Ohio (9)
Pennsylvania (69)
South America (21)
Southern California (148)
Tennessee (2)
Texas (47)
United States (1306)
Utah (17)
Virginia (11)
Washington State (23)
Wisconsin (1)
15,147 Results for "265".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
InterCure Announces Preliminary Estimated 2025 Revenue of NIS 265 Million, Positive Adjusted EBITDA and Cash of NIS 43 Million
February 19, 2026
·
8 min read
Press Releases
AvantGuard Awarded $2.65 Million in NIH Grants to Advance Next-Generation Antimicrobial Technologies
November 4, 2025
·
1 min read
Press Releases
GENFIT to receive a €26.5 million milestone payment following the approval of pricing and reimbursement of Ipsen’s Iqirvo® in Italy
May 21, 2025
·
5 min read
IPA Announces Closing of $1.265 Million Public Offering of Common Shares
ImmunoPrecise Antibodies Ltd., announced the closing of its $1.265 million underwritten public offering of 1,265,000 common shares, including 165,000 common shares issued pursuant to the full exercise by the underwriter of its over-allotment option.
December 8, 2023
·
4 min read
Press Releases
NeuroOne® Announces $2.65 Million Equity Financing And $3.0 Million Credit Facility
August 5, 2024
·
5 min read
Hyperthermia Cancer Treatment Market Size to Reach US$ 265 Million by 2030
The global hyperthermia cancer treatment market size is expected to reach US$ 265 million by 2030 from US$ 160 million in 2020, growing at a CAGR of 5.8% from 2021 to 2030.
October 4, 2022
·
9 min read
Biotech Bay
Pionyr Immunotherapeutics’ MARCO-targeting Antibody Program, PY265, for Treatment of Solid Tumors Featured at SITC 2022
Pionyr Immunotherapeutics, Inc. will present pre-clinical data showing the potential for its PY265 program to treat solid tumors, as a single agent and in combination with checkpoint inhibitor (CPI) therapy.
November 7, 2022
·
4 min read
Deals
Coya Therapeutics Announces $26.5 Million Private Placement
Coya Therapeutics, Inc. announced today that it has entered into definitive securities purchase agreements for the purchase and sale of an aggregate of 4,370,382 shares of its common stock at a purchase price of $6.06 per share of common stock.
December 6, 2023
·
5 min read
Deals
Coya Therapeutics Announces Closing of $26.5 Million Private Placement
Coya Therapeutics, Inc. announced today the closing of the sale of an aggregate of 4,370,382 shares of its common stock at a purchase price of $6.06 per share of common stock, in a private placement priced at-the-market under Nasdaq rules.
December 12, 2023
·
4 min read
Lone Star Bio
Savara Announces Debt Refinancing of $26.5M Credit Facility With Silicon Valley Bank
Savara Inc. today announced that it entered into a term loan agreement of $26.5 million with Silicon Valley Bank to replace its existing credit facility with the bank.
April 22, 2022
·
5 min read
1 of 1,515
Next
